Loading...

Hospitalization and Survival in Patients Using Epoprostenol for Injection in the PROSPECT Observational Study

BACKGROUND: Few studies have prospectively reported outcomes in patients with pulmonary arterial hypertension (PAH) treated with epoprostenol in the modern-day era of oral therapy and combination treatments. The Registry to Prospectively Describe Use of Epoprostenol for Injection (Veletri, prolonged...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Chest
Main Authors: Frantz, Robert P., Schilz, Robert J., Chakinala, Murali M., Badesch, David B., Frost, Adaani E., McLaughlin, Vallerie V., Barst, Robyn J., Rosenberg, Daniel M., Miller, Dave P., Hartline, Brian K., Benton, Wade W., Farber, Harrison W.
Format: Artigo
Sprog:Inglês
Udgivet: American College of Chest Physicians 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314821/
https://ncbi.nlm.nih.gov/pubmed/25320967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-1004
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!